Tatva Chintan Pharma Chem Limited (BOM:543321)

Market Cap	25.94B +58.5%
Revenue (ttm)	4.80B +28.5%
Net Income	327.63M +129.2%
EPS	14.02 +129.6%
Shares Out	n/a
PE Ratio	79.18
Forward PE	42.28
Dividend	1.00 (0.09%)
Ex-Dividend Date	Sep 12, 2025

Volume	1,273
Average Volume	2,653
Open	1,070.20
Previous Close	1,099.80
Day's Range	1,053.95 - 1,119.70
52-Week Range	610.00 - 1,603.60
Beta	n/a
RSI	45.21
Earnings Date	May 4, 2026

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal car...

• Industry: Chemicals and Allied Products
• Founded: 1996
• Employees: 679
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543321

Financial Performance

In fiscal year 2025, Tatva Chintan Pharma Chem's revenue was 3.83 billion, a decrease of -2.74% compared to the previous year's 3.94 billion. Earnings were 57.13 million, a decrease of -81.18%.